The role of Ivermectin in COVID -۱۹ |management, issues and challenges

Publish Year: 1400
نوع سند: مقاله ژورنالی
زبان: English
View: 141

متن کامل این Paper منتشر نشده است و فقط به صورت چکیده یا چکیده مبسوط در پایگاه موجود می باشد.
توضیح: معمولا کلیه مقالاتی که کمتر از ۵ صفحه باشند در پایگاه سیویلیکا اصل Paper (فول تکست) محسوب نمی شوند و فقط کاربران عضو بدون کسر اعتبار می توانند فایل آنها را دریافت نمایند.

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_APT-1-2_006

تاریخ نمایه سازی: 9 مهر 1401

Abstract:

Why was Ivermectin not mentioned by the medical community in the treatment of COVID-۱۹? In a pandemic, emergency physicians don't have time to wait for validated studies before we try something.An example of a sentence that we hear a lot from parents of children in the community:Here are so many facts to question now: The COVID-۱۹ mandatory injection for children, now going into effect nationwide has me shuddering! Where are the national baseline tests for antibodies for these kids, before they must have this experimental vaccine? It is still experimental people! (Until now, drugs widely used under the mandatory three-year data study by the FDA, are deemed experimental).In the last two years, humans have witnessed a deadly catastrophe called the Corona virus. Severe acute respiratory syndrome coronavirus ۲ (SARS-CoV-۲) infection has turns to a pandemic all around the world. Despite the importance of vaccination, more efficient drugs are required to treat or manage coronavirus disease-۱۹.According to the Centers for Disease Control and Prevention, ۱۵۰,۰۰۰-۲۰۰,۰۰۰ new cases of COVID-۱۹ are reported in the United States every day. In the United States, COVID-۱۹ causes more than ۲۰۰۰ deaths a day and more than ۳۰۰,۰۰۰ deaths since January ۲۰۲۰(۱). Many drugs, including Hydroxychloroquine, have been introduced for treatment, but clinical trials have shown multiple side effects and less benefit in treating the disease with this drug (۲).